©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Oct 15, 2016; 7(18): 481-482
Published online Oct 15, 2016. doi: 10.4239/wjd.v7.i18.481
Published online Oct 15, 2016. doi: 10.4239/wjd.v7.i18.481
Response to comment on: Statin use and risk of diabetes mellitus
Bharti Chogtu, Kurady Laxminarayana Bairy, Department of Pharmacology, Kasturba Medical College, Manipal University, Manipal 576104, Karnataka, India
Rahul Magazine, Department of Pulmonary Medicine, Kasturba Medical College, Manipal University, Manipal 576104, Karnataka, India
Author contributions: Chogtu B wrote this letter; Magazine R revised the letter; Bairy KL edited the letter.
Conflict-of-interest statement: The authors declare that they don’t have any conflict of interest.
Correspondence to: Dr. Bharti Chogtu, MD, Associate Professor, Department of Pharmacology, Kasturba Medical College, Manipal University, SH 65, Madhav Nagar, Manipal 576104, Karnataka, India. bhartimagazine@gmail.com
Telephone: +91-0820-2922582
Received: May 19, 2016
Peer-review started: May 20, 2016
First decision: July 4, 2016
Revised: July 28, 2016
Accepted: August 17, 2016
Article in press: August 18, 2016
Published online: October 15, 2016
Processing time: 144 Days and 22.7 Hours
Peer-review started: May 20, 2016
First decision: July 4, 2016
Revised: July 28, 2016
Accepted: August 17, 2016
Article in press: August 18, 2016
Published online: October 15, 2016
Processing time: 144 Days and 22.7 Hours
Core Tip
Core tip: The statement “Pravastatin has shown to decrease the risk of developing diabetes by 30%” is correct and had been wrongly referenced in “Statin use and risk of diabetes mellitus” by Chogtu et al.